Viewing Study NCT06079411



Ignite Creation Date: 2024-05-06 @ 7:37 PM
Last Modification Date: 2024-10-26 @ 3:10 PM
Study NCT ID: NCT06079411
Status: RECRUITING
Last Update Posted: 2024-03-08
First Post: 2023-09-26

Brief Title: Virtual Therapeutics for MCI
Sponsor: Istituto Auxologico Italiano
Organization: Istituto Auxologico Italiano

Study Overview

Official Title: Low-Cost Virtual Therapeutics and Digital Biomarkers for the Early Assessment and Personalized Treatment of Mild Cognitive Impairment
Status: RECRUITING
Status Verified Date: 2024-03
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: VR-MCI
Brief Summary: Mild Cognitive Impairment MCI is a term used to describe the transitional stage that occurs between normal aging and the onset of dementia Spatial disorientation is often considered a significant indicator for diagnosing dementia Numerous studies have documented deficits in both the allocentric and egocentric spatial frames of reference as well as difficulties in transitioning between them in individuals with MCI Rapid advances in computing technology have enabled researchers to conduct cognitive training and rehabilitation interventions with the assistance of technology Therefore the aim of the study is to use virtual therapeutics to train MCI spatial memory
Detailed Description: The current study aims to design develop and test virtual therapeutics to train MCI spatial memory through virtual reality rehabilitation 36 Participants will be randomly assigned to three different conditions embodied low-end spatial VR training vs the treatment as usual TAU ie visuospatial paper and pencil stimulation vs a non-embodied low-end spatial VR training The three conditions will consist of at least 8 sessions of 3040 minutes 3 times a week

The study will measure changes in spatial memory in particular in egocentric and allocentric memory Each patient will be tested 3 times 3 weeks before the pre-test control waiting period at the pre-test and after the intervention namely post-test 3 time points

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None